BioNTech gibt Gründung eines interdisziplinären mRNA-Exzellenzzentrums für gemeinsame Forschung mit dem Weizmann Institute of Science in Israel bekannt
01 mars 2023 08h00 HE
|
BioNTech SE
JERUSALEM, Israel, 1. März 2023 – BioNTech SE (Nasdaq: BNTX, „BioNTech“, „das Unternehmen“) gab heute bekannt, dass das Unternehmen eine Absichtserklärung (Memorandum of Understanding) mit dem...
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
01 mars 2023 08h00 HE
|
BioNTech SE
JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of...
Crone and Aboudi Join Forces to Form Crone Law Group Israel
06 févr. 2023 09h35 HE
|
The Crone Law Group, P.C.
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- The Crone Law Group, P.C. (CLG) with offices in North America and China, and David Aboudi Adv., operating in Israel and the United...
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
10 janv. 2023 08h30 HE
|
Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (CSE: CMND) (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on...
BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel
05 janv. 2023 13h40 HE
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of BioLineRx Ltd. (NASDAQ:...
CEO’s Letter to Shareholders
15 déc. 2022 08h00 HE
|
BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (C.S.E.: BYND) ("BYND Cannasoft" or the "Company") today issued a...
Maris-Tech Announces $3.4 Million of Order Backlog as of January 1, 2022
08 déc. 2022 09h00 HE
|
Maris-Tech Ltd.
REHOVOT, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech” or the "Company"), a B2B provider of intelligent video transmission technology, today announced that...
Medigus Announces Cash Capital Distribution of $1.6 Million
18 nov. 2022 08h30 HE
|
Medigus Ltd
The Company will provide an update regarding the distribution date Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical...
BiondVax Announces Plan to Implement ADS Ratio Change
10 nov. 2022 16h00 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company focused on developing, manufacturing, and...
Tel Aviv Listed Together Pharma’s Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ Subsidiary Sign First Commercial Agreement for Medical Cannabis Products
27 oct. 2022 09h00 HE
|
BYND Cannasoft Enterprises, Inc.
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 27, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today its...